healthprotocol.wiki

anonymous_2018_rct_flucytosine-plus-fluconazole-is-noninferior-to-amphotericin-b-in-treating-cryptococcal-meningitis

7 findings

Protocol
medication-amphotericin-b-two-weeks-combined-generic
Outcome
biomarker-renal-kidney-injury-incidence-cohort-measured
n
229
effect
-15
attribution
70
Protocol
medication-oral-flucytosine-plus-fluconazole-two-weeks-generic
Outcome
biomarker-renal-kidney-injury-incidence-cohort-measured
n
225
effect
15
attribution
70
Protocol
medication-amphotericin-b-one-week-combined-generic
Outcome
cerebrospinal-fluid-csf-fungal-clearance-rate-log10-cfu-per-ml-per-day-measured
n
224
effect
15
attribution
80
Protocol
medication-amphotericin-b-two-weeks-combined-generic
Outcome
cerebrospinal-fluid-csf-fungal-clearance-rate-log10-cfu-per-ml-per-day-measured
n
229
effect
15
attribution
80
Protocol
medication-oral-flucytosine-plus-fluconazole-two-weeks-generic
Outcome
cerebrospinal-fluid-csf-fungal-clearance-rate-log10-cfu-per-ml-per-day-measured
n
225
effect
-15
attribution
80
Protocol
medication-amphotericin-b-two-weeks-combined-generic
Outcome
safety-treatment-related-grade-4-anemia-incidence-cohort-measured
n
229
effect
-70
attribution
85
Protocol
medication-oral-flucytosine-plus-fluconazole-two-weeks-generic
Outcome
safety-treatment-related-grade-4-anemia-incidence-cohort-measured
n
225
effect
70
attribution
85